[250 Pages Report] Expanding at a high CAGR of 8.4%, the global automated cell culture systems market is projected to increase from a valuation of US$ 10.91 Billion in 2022 to US$ 20.87 Billion by 2030.
Automated cell culture systems currently account for 44.5% share in the global cell culture market. Expansion of the automated cell culture systems market is being fuelled by rising stem cell research and development, drug breakthroughs, and increased investments towards the development of innovative products.
| Attribute | Details |
|---|---|
| Automated Cell Culture Systems Market Size (2022) | US$ 10.91 Billion |
| Revenue Forecast (2030) | US$ 20.87 Billion |
| Global Market Growth Rate (2022 to 2030) | 8.4% CAGR |
| Europe Marker Share | 35.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 8.23% |
| H1, 2022 Projected | 8.44% |
| H1, 2022 Outlook | 8.24% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 20 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (+) 01 ↑ |
H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 20 BPS. However, In H1-2022, the market growth rate of automated cell culture systems is expected to incline by 01 basis point share (BPS), as per FMI analysis.
The market for automated cell culture systems observes a decline in the BPS values due to the initial costs of automation and operational management. Moreover, equipment maintenance adds to additional cost overheads, thus proposing a hindrance to the overall market growth.
Although there are additional costs to automated cell culture systems, the future outlook is expected to be positive in terms of sales within the market. This is because automated systems can assist with bulk manufacturing of cell culture with management of cross contamination, within a closed system.
The key developments in the market include the advancement of the bioprocessing industry around the globe, especially within the South Asian region.
In laboratories, automated cell culture instruments are used because they mechanically accomplish the duties needed in creating and sustaining a cell culture. These instruments are frequently employed in cytology laboratories.
Automated cell culture equipment can execute operations such as diluting samples, cultivating cultures in liquid with constant spinning, plating cultures, and placing cultures in wells. The capacity of automated cell culture systems to develop optimal cell lines across the entire range of seeding, feeding, massaging, and cell multiplication has gained in popularity.
They help achieve strict standards demands while also decreasing contamination and human mistake. In the life sciences business, automated systems are employed for a variety of cell-based screening applications for both scientific and business purposes. The automated cell culture devices market expanded at a CAGR of 6.6% from 2015 to 2021.
Demand for automated cell culture equipment is increasing as the use of high-throughput cell lines in drug discovery research grows. The automated cell culture system demand is expected to progress at a CAGR of 8.4% from 2022 to 2030, with the global market predicted to reach a valuation of US$ 20.87 Bn by 2030.
Automated cell culture facilitates the production of large numbers of high-quality cell lines for pharmacological studies, resulting in improved product safety and efficacy. Other common scientific applications include RNA interference (RNAi), cell-based drug transport, metabolism, and toxicology studies.
Principal Consultant
“Development of Novel 3D Cell Culture Techniques & Growing Need of Cell Culture Technology”
Development of novel three-dimensional cell culture techniques, as well as the increased demand for these techniques in biopharmaceutical research and vaccine production, is driving the market for automated cell culture systems.
The benefits of cell-based vaccinations are becoming more widely recognized. Researchers and manufacturers have been pushed to develop automated cell culture-based immunizations by increased global demand for novel vaccines to restrict and cure the coronavirus's transmission, as well as strict safety standards.
“Advancement in Technologies Driving Consumption of Automated Cell Culture Systems”
High-throughput screening technology has shown to be indispensable, particularly when a huge number of biological/chemical substances are being examined to treat a specific condition.
As a result, the automated cell culture systems market is expected to be driven by the use of automation and robots for speedy assessment of biochemical or biological activities.
“High Investments in R&D of Oncology Driving Europe Automated Cell Culture Systems Market Growth”
The global automated cell culture equipment market has been studied across North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).
North America and Europe regional markets account for more than half of the global market share for automated cell culture systems. This could be related to a rise in the use of automated cell culture vessels as a result of an increase in oncology research and drug development.
The presence of excellent laboratory facilities is also likely to help these two regions to stand out. In 2022, North America is expected to account for 25.1% and Europe is likely to hold 35.7% of the global market share.
Given the growing demand for cell-based medicine delivery, East Asia will be the most attractive market for automated cell culture products. East Asia currently is likely to account for 20.9% of the global market share.
In 2022, South Asia & Oceania together may account for 14.2% of the global market share. This is due to the technological innovations such as next-generation sequencing, increased awareness, increased healthcare expenditure in national budgets, early availability of modern technologies, and fast-developing of research activities across the region.
The Latin America & MEA automated cell culture systems markets are expected to progress at a slightly slower rate than other regions but are expected to pick up pace towards the end of the projection period. At present, Latin America & MEA are predicted to account for 2.4% & 1.5% of the global market share, respectively.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Rising Cases of Cancer Driving Sales of Automated Cell Culture Systems”
Because of government assistance and strategic initiatives, the China automated cell culture systems market is expected to grow rapidly. To cater for the enormous patient population, China is putting a larger emphasis on technological advancements.
A high need for innovative therapies and solutions has arisen due to an increase in the number of elderly people as well as a high cancer incidence. Progress in the field of regenerative medicine, as well as well-developed sophisticated healthcare systems, are driving automated cell culture systems market expansion in China.
“High Spending on Healthcare Facilities Augmenting Sales Growth of Automated Cell Culture Systems”
The United States currently dominates the North America automated cell culture systems market, and this trend is likely to continue over the projection period. Growing demand for customized medications, as well as the existence of prominent companies in the market, is largely responsible for the market expansion.
Additionally, because healthcare is one of the country's top objectives, the US government is supportive of medical research. Increasing investments in the biomedical engineering industry are also boosting the country's market growth.
“Improved Technologies & Increasing Funding in R&D Boost Sales of Biotech Companies”
Over the projected period, biotech companies are expected to progress at a fast pace. The presence of a significant number of biotechnology companies, an increase in R&D investment in these firms, and a greater demand for alternative testing methods over animal techniques are all primary market drivers.
3D cell culture has advantages over 2D cell culture in terms of suitable oxygen and nutritional gradients, non-uniform cell-to-cell contacts, and realistic cell-to-cell interactions. Because of these factors, 3D cell culture is more suitable for drug discovery and advancement, leading in rising demand for automated cell culture systems.
The COVID-19 pandemic impacted a wide range of industries all across the world. Manufacturing facilities were shut down during the early stages of the pandemic. Furthermore, the financial collapse that followed the pandemic caused a significant delay in the healthcare industry's development.
Local producers and innovators, on the other hand, have a lot of opportunities in the automated cell culture systems market to develop cost-effective automated cell culture products. Demand for diagnostic and therapeutic facilities is steadily increasing, which may prompt a slew of new firms to enter the market with innovative products.
The COVID-19 pandemic is projected to tip the market in favour of automated cell culture systems, because research operations to generate efficient and effective COVID-19 vaccinations necessitate cell lines. Even once a suitable vaccine has been discovered, demand for cell lines will continue to rise as research in this field progresses.
Manufacturers of automated cell culture systems have been heavily investing in research to develop long-term solutions for both, biopharmaceutical and packaging industries. Sustainable vessel solutions are primarily made up of recyclable plastics and glass bottles.
Recycling, on the other hand, is not without its difficulties. Recycling a multi-layer flexible vessel with barrier material and base material plastic is a time-consuming task.
As a result, companies are actively investing in research aimed at making the recycling process easier. Automated cell culture systems market players are also concentrating on innovations and collaborations to enhance their market presence.
Some of the market players included in this report are Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza Group Ltd, Sartorius AG, Tecan Trading AG, Hamilton Medical AG, Biospherix, and Promocell GmbH.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2030 |
| Historical Data Available for | 2015 to 2021 |
| Market Analysis | US$ Billion for Value |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Market Segments Covered |
|
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The global automated cell culture systems market is predicted to progress at a high CAGR of 8.4% from 2022 to 2030.
The global market for automated cell culture systems is currently worth US$ 10.91 Bn.
Key suppliers of automated cell culture systems are Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza Group Ltd, Sartorius AG, Tecan Trading AG, Hamilton Medical AG, Biospherix, and Promocell GmbH.
By the end of 2030, automated cell culture system demand is anticipated to attain a market valuation of US$ 20.87 Bn.
The Europe automated cell culture systems market currently holds 35.7% share in the global market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Service Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Global Healthcare Outlook
4.1.3. Global Life Science Market Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. Technology Development
4.2.2. End User Demand
4.2.3. Regulatory Imposition
4.2.4. Technology Shortcomings
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. COVID19 Crisis Analysis
4.4.1. Current COVID19 Statistics and Probable Future Impact
4.4.2. Current GDP Projection and Probable Impact
4.4.3. Current Economic Projection as compared to 2008 Economic analysis
4.4.4. COVID19 and Impact Analysis
4.4.4.1. Revenue By Service
4.4.4.2. Revenue By Country
4.4.5. 2022 Market Scenario
4.4.6. Quarter by Quarter Forecast
4.4.7. Projected recovery Quarter
4.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact
5. Market Context
5.1. Regulatory Scenario
5.2. Value Chain Analysis
5.3. Key Strategies Adopted By Application Service Providers
5.4. Technology Adoption Analysis
6. Global Automated Cell Culture Systems Market Value (US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Opportunity Analysis, 2022-2030
7. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, By Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) By Product Type, 2015–2021
7.3. Current and Future Market Size (US$ Mn) and Forecast By Product Type, 2022-2030
7.3.1. Automated Cell Culture Storage Equipment
7.3.2. Automated Cell Culture Vessels
7.3.3. Bioreactors
7.3.4. Consumables
7.4. Market Attractiveness Analysis By Product Type
8. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, By Cell Culture Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Cell Culture Type, 2015–2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cell Culture Type, 2022-2030
8.3.1. Finite Cell Line Cultures
8.3.2. Infinite Cell Line Cultures
8.4. Market Attractiveness Analysis By Cell Culture Type
9. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Application, 2015–2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2030
9.3.1. Drug Development
9.3.2. Stem Cell Research
9.3.3. Regenerative Medicine
9.3.4. Cancer Research
9.4. Market Attractiveness Analysis By Application
10. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2030
10.3.1. Biotech Companies
10.3.2. Research Organizations
10.3.3. Academic Institutes
10.4. Market Attractiveness Analysis By End User
11. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, by Region
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) By Region, 2015–2021
11.3. Current and Future Market Size (US$ Mn) and Forecast By Region, 2022-2030
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021
12.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product Type
12.3.3. By Cell Culture Type
12.3.4. By Application
12.3.5. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
13. Latin America Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021
13.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product Type
13.3.3. By Cell Culture Type
13.3.4. By Application
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Europe Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021
14.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product Type
14.3.3. By Cell Culture Type
14.3.4. By Application
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. South Asia Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021
15.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product Type
15.3.3. By Cell Culture Type
15.3.4. By Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. East Asia Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021
16.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product Type
16.3.3. By Cell Culture Type
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Oceania Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021
17.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product Type
17.3.3. By Cell Culture Type
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021
18.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Product Type
18.3.3. By Cell Culture Type
18.3.4. By Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Emerging & Key Countries Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
19.1. U.S. Automated Cell Culture Systems Market Analysis
19.1.1. By Product Type
19.1.2. By Cell Culture Type
19.1.3. By Application
19.1.4. By End User
19.2. Canada Automated Cell Culture Systems Market Analysis
19.2.1. By Product Type
19.2.2. By Cell Culture Type
19.2.3. By Application
19.2.4. By End User
19.3. Mexico Automated Cell Culture Systems Market Analysis
19.3.1. By Product Type
19.3.2. By Cell Culture Type
19.3.3. By Application
19.3.4. By End User
19.4. Brazil Automated Cell Culture Systems Market Analysis
19.4.1. By Product Type
19.4.2. By Cell Culture Type
19.4.3. By Application
19.4.4. By End User
19.5. U.K. Automated Cell Culture Systems Market Analysis
19.5.1. By Product Type
19.5.2. By Cell Culture Type
19.5.3. By Application
19.5.4. By End User
19.6. Germany Automated Cell Culture Systems Market Analysis
19.6.1. By Product Type
19.6.2. By Cell Culture Type
19.6.3. By Application
19.6.4. By End User
19.7. France Automated Cell Culture Systems Market Analysis
19.7.1. By Product Type
19.7.2. By Cell Culture Type
19.7.3. By Application
19.7.4. By End User
19.8. Italy Automated Cell Culture Systems Market Analysis
19.8.1. By Product Type
19.8.2. By Cell Culture Type
19.8.3. By Application
19.8.4. By End User
19.9. Spain Automated Cell Culture Systems Market Analysis
19.9.1. By Product Type
19.9.2. By Cell Culture Type
19.9.3. By Application
19.9.4. By End User
19.10. BENELUX Automated Cell Culture Systems Market Analysis
19.10.1. By Product Type
19.10.2. By Cell Culture Type
19.10.3. By Application
19.10.4. By End User
19.11. Russia Automated Cell Culture Systems Market Analysis
19.11.1. By Product Type
19.11.2. By Cell Culture Type
19.11.3. By Application
19.11.4. By End User
19.12. China Automated Cell Culture Systems Market Analysis
19.12.1. By Product Type
19.12.2. By Cell Culture Type
19.12.3. By Application
19.12.4. By End User
19.13. India Automated Cell Culture Systems Market Analysis
19.13.1. By Product Type
19.13.2. By Cell Culture Type
19.13.3. By Application
19.13.4. By End User
19.14. Japan Automated Cell Culture Systems Market Analysis
19.14.1. By Product Type
19.14.2. By Cell Culture Type
19.14.3. By Application
19.14.4. By End User
19.15. South Korea Automated Cell Culture Systems Market Analysis
19.15.1. By Product Type
19.15.2. By Cell Culture Type
19.15.3. By Application
19.15.4. By End User
19.16. ASEAN Automated Cell Culture Systems Market Analysis
19.16.1. By Product Type
19.16.2. By Cell Culture Type
19.16.3. By Application
19.16.4. By End User
19.17. Australia Automated Cell Culture Systems Market Analysis
19.17.1. By Product Type
19.17.2. By Cell Culture Type
19.17.3. By Application
19.17.4. By End User
19.18. New Zealand Automated Cell Culture Systems Market Analysis
19.18.1. By Product Type
19.18.2. By Cell Culture Type
19.18.3. By Application
19.18.4. By End User
19.19. GCC Countries Automated Cell Culture Systems Market Analysis
19.19.1. By Product Type
19.19.2. By Cell Culture Type
19.19.3. By Application
19.19.4. By End User
19.20. Turkey Automated Cell Culture Systems Market Analysis
19.20.1. By Product Type
19.20.2. By Cell Culture Type
19.20.3. By Application
19.20.4. By End User
19.21. South Africa Automated Cell Culture Systems Market Analysis
19.21.1. By Product Type
19.21.2. By Cell Culture Type
19.21.3. By Application
19.21.4. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
20.3.1. Regional Footprint by Players
20.3.2. Service Foot print by Players
20.3.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive (Tentative List)
21.3.1. Thermo Fisher Scientific
21.3.1.1. Overview
21.3.1.2. Service Portfolio
21.3.1.3. Profitability by Market Segments(Service/Channel/Country)
21.3.1.4. Service Footprint
21.3.1.5. Strategy Overview
21.3.1.5.1. Marketing Strategy
21.3.1.5.2. Service Strategy
21.3.1.5.3. Channel Strategy
21.3.2. Corning Incorporated
21.3.2.1. Overview
21.3.2.2. Service Portfolio
21.3.2.3. Profitability by Market Segments(Service/Channel/Country)
21.3.2.4. Service Footprint
21.3.2.5. Strategy Overview
21.3.2.5.1. Marketing Strategy
21.3.2.5.2. Service Strategy
21.3.2.5.3. Channel Strategy
21.3.3. Merck KGaA
21.3.3.1. Overview
21.3.3.2. Service Portfolio
21.3.3.3. Profitability by Market Segments(Service/Channel/Country)
21.3.3.4. Service Footprint
21.3.3.5. Strategy Overview
21.3.3.5.1. Marketing Strategy
21.3.3.5.2. Service Strategy
21.3.3.5.3. Channel Strategy
21.3.4. Lonza Group Ltd
21.3.4.1. Overview
21.3.4.2. Service Portfolio
21.3.4.3. Profitability by Market Segments(Service/Channel/Country)
21.3.4.4. Service Footprint
21.3.4.5. Strategy Overview
21.3.4.5.1. Marketing Strategy
21.3.4.5.2. Service Strategy
21.3.4.5.3. Channel Strategy
21.3.5. Sartorius AG
21.3.5.1. Overview
21.3.5.2. Service Portfolio
21.3.5.3. Profitability by Market Segments(Service/Channel/Country)
21.3.5.4. Service Footprint
21.3.5.5. Strategy Overview
21.3.5.5.1. Marketing Strategy
21.3.5.5.2. Service Strategy
21.3.5.5.3. Channel Strategy
21.3.6. Tecan Trading AG
21.3.6.1. Overview
21.3.6.2. Service Portfolio
21.3.6.3. Profitability by Market Segments(Service/Channel/Country)
21.3.6.4. Service Footprint
21.3.6.5. Strategy Overview
21.3.6.5.1. Marketing Strategy
21.3.6.5.2. Service Strategy
21.3.6.5.3. Channel Strategy
21.3.7. Hamilton Medical AG
21.3.7.1. Overview
21.3.7.2. Service Portfolio
21.3.7.3. Profitability by Market Segments(Service/Channel/Country)
21.3.7.4. Service Footprint
21.3.7.5. Strategy Overview
21.3.7.5.1. Marketing Strategy
21.3.7.5.2. Service Strategy
21.3.7.5.3. Channel Strategy
21.3.8. Biospherix
21.3.8.1. Overview
21.3.8.2. Service Portfolio
21.3.8.3. Profitability by Market Segments(Service/Channel/Country)
21.3.8.4. Service Footprint
21.3.8.5. Strategy Overview
21.3.8.5.1. Marketing Strategy
21.3.8.5.2. Service Strategy
21.3.8.5.3. Channel Strategy
21.3.9. Promocell GmbH
21.3.9.1. Overview
21.3.9.2. Service Portfolio
21.3.9.3. Profitability by Market Segments(Service/Channel/Country)
21.3.9.4. Service Footprint
21.3.9.5. Strategy Overview
21.3.9.5.1. Marketing Strategy
21.3.9.5.2. Service Strategy
21.3.9.5.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports
Automated Cell Culture Systems Market
